Xact Robotics, a Caesarea, Israel-based developer of robotic navigation and steering solutions for percutaneous image-guided procedures, raised $5m in Series C funding.
The company intends to use the funds for the launch and operation of seven Centers of Excellence in the US, Europe and Israel, where it expects that hundreds of clinical procedures will be conducted within the next 12 months with the XACT robotic navigation and steering system.
Founded in 2013 and led by Chen Levin, CEO, Xact Robotics develops robotic navigation and steering solutions for percutaneous image-guided procedures.
The company’s XACT image guided robotic navigation and steering system accurately and systematically accesses any target anywhere in the body, in any clinical setting, and with all imaging modalities.
Xact Robotics has received CE Mark approval for its robotics navigation and steering system for image-guided percutaneous procedures, such as ablations and biopsies.
The system can be used to accurately access any target in the abdomen in CT-guided percutaneous procedures. The physician plans the procedure on the XACT system by selecting a target and an entry point. The system then recommends a trajectory for approval and for selection of verification checkpoints along the trajectory. Once approved by the physician, the desired tool is attached to the robot allowing it to perform the needle insertion and steering according to the approved trajectory, while the progress is being monitored by the physician. The system actively compensates for breathing and patient movement during the procedure enabling fast, accurate and safe performance of insertion to the desired site of interest. Real-time, closed-loop control coupled with the ability to perform complex angulation 3D trajectories, mean that any deviation from the original planned pathway can be immediately detected and corrected without the need for needle reinsertion or patient repositioning. The XACT system is expected to allow physicians to reach the desired site of interest in image-guided percutaneous procedures, while reducing the learning curve for physicians performing image-guided percutaneous procedures.
The first Center of Excellence has already been launched earlier this year at the Hadassah Medical Center in Jerusalem, Israel, where the first cases were completed as part of a clinical trial by Professor Nahum Goldberg, M.D., the Head of Interventional Oncology Unit and Director of the Applied Radiology Research Lab at Hadassah Medical Center, and the principal investigator in this study using XACT’s novel system to target lesions. Later this year, the system’s application is expected to be expanded for use in additional clinical centers and with other imaging modalities, such as Cone-Beam CT and Fluoroscopy, and for additional indications, including spinal and lung procedures.
The technology originated from the lab of Prof. Moshe Shoham at the Technion Israel Institute of Technology.
FinSMEs
17/09/2018